Scientists create vaccine against prostate cancer

• April 26, 2024

English scientists from the University of Leeds in collaboration with the Rochester clinic of the United States, approved a new vaccine for the treatment of prostate cancer . Unlike traditional vaccines that act to protect against infection, those of Cancer They work by causing the immune system to attack tumors that are already in the body.

In an interview for GetQoralHealth , the prostate cancer specialistCarlos Pacheco, explains the causes of prostate cancer:

These vaccines are created based on DNA specifically and are directed to markers located on the surface of the cancer cells , called antigens . The endogenous expression of the antigens within the cells can induce a complete and lasting immune response. In fact, the extraordinary development of DNA vaccines places them as the most successful alternative in the control of different diseases, which are not limited to infectious diseases.

In the study published in the magazine Nature Medecine It was reported that the new vaccine managed to cure 80% of mice against previously established tumors, without causing the apparent side effects caused by current treatments such as chemotherapy or radiation and scientists say that the most important thing is that healthy cells from both the prostate and other tissues were not affected.

It is important to emphasize that this is just a first stage and it is necessary to carry out more studies to verify the effect on human beings. This study opens doors to develop a new potential therapy of anti-tumor agents with the creation of new vaccines focused on other types of Cancer As the melanoma .

Other sources:

BBC World

Biomed Magazine (2000)

Video Medicine: Is the Next Big Step in Cancer Therapy: Personalized Vaccines? (April 2024).